UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

ANEBULO PHARMACEUTICALS, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware   85-1170950
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
   
1415 Ranch Road 620 South, Suite 201, Lakeway, Texas   78734
(Address of principal executive offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class
to be so registered
  Name of each exchange on which
each class is to be registered
Common Stock, par value $0.001 per share   The Nasdaq Stock Market LLC


 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. [X]

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. [  ]

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. [  ]

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-254979

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

None
Title of Class

 

 

 

 
 

 

Item 1.Description of Registrant’s Securities to Be Registered.

 

The information required by this Item is included under the captions “Description of Capital Stock” (pages 92 - 95), “ Dividend Policy” (page 48) and “Shares Eligible for Future Sale” (pages 96 - 97) of the Prospectus included as part of the Registrant’s Registration Statement on Form S-1, Registration No. 333-254979 (“Form S-1”), which information is incorporated herein by this reference.

 

Item 2.Exhibits.

 

The following documents are included as exhibits to Form S-1, as indicated, and are incorporated herein by this reference:

 

  1. Specimen Stock Certificate for Common Stock (Exhibit 4.1 to Form S-1).
     
2. (a) Form of Second Amended and Restated Certificate of Incorporation of Anebulo Pharmaceuticals, Inc. (Exhibit 3.3 to Form S-1).
     
  (b)

Form of Amended and Restated By-laws of Anebulo Pharmaceuticals, Inc. (Exhibit 3.4 to Form S-1).

 

2
 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  ANEBULO PHARMACEUTICALS, INC.
     
Dated: May 5, 2021 By: /s/ Daniel Schneeberger, M.D.
    Daniel Schneeberger, M.D.
    Chief Executive Officer

 

3
 

 

EXHIBIT INDEX

 

The following documents are included as exhibits to the Registrant’s Registration Statement on Form S-1, Registration No. 333-254979, to be declared effective on May 6, 2021 (“Form S-1”), as indicated, and are incorporated herein by this reference:

 

  1.Specimen Stock Certificate for Common Stock (Exhibit 4.1 to Form S-1).
     
2. (a) Form of Second Amended and Restated Certificate of Incorporation of Anebulo Pharmaceuticals, Inc. (Exhibit 3.3 to Form S-1).
     
  (b)

Form of Amended and Restated By-laws of Anebulo Pharmaceuticals, Inc. (Exhibit 3.4 to Form S-1).

 

4